Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

APO-FLUTICASONE AQUEOUS NASAL SPRAY 50MCG/SPRAY

Approval Number

SIN13983P

Drug Name

APO-FLUTICASONE AQUEOUS NASAL SPRAY 50MCG/SPRAY

Product Name

APO-FLUTICASONE AQUEOUS NASAL SPRAY 50MCG/SPRAY

Approval Date

July 5, 2011

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

SPRAY, METERED

Route of Administration

NASAL

Medical Information

ATC Code

R01AD08

ATC Item Name

fluticasone

Manufacturer Information

Pharmaceutical Manufacturer

PHARMAFORTE SINGAPORE PTE LTD

Manufacturers

APOTEX INC. (RICHMOND HILL)

Active Ingredients

Ingredient Name

FLUTICASONE PROPIONATE (micronized)

Strength

0.05G/100G

Drug MonographFluticasone propionate

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

APO-FLUTICASONE AQUEOUS NASAL SPRAY 50MCG/SPRAY - HSA Approval | MedPath